Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Power of Prescription Drug Monitoring Programs (PDMP) in an American Health Crisis

A 2010 national youth drug abuse study revealed some disturbing results. In 2009, the drugs of choice for 6 of 10 drug abusers in the 12th grade were prescription pharmaceuticals. Likewise, data from a 2008 SAMSHA report revealed that the previous decade had seen a four-fold increase in the number of those seeking treatment for addiction…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

A 2010 national youth drug abuse study revealed some disturbing results. In 2009, the drugs of choice for 6 of 10 drug abusers in the 12th grade were prescription pharmaceuticals. Likewise, data from a 2008 SAMSHA report revealed that the previous decade had seen a four-fold increase in the number of those seeking treatment for addiction to prescription painkillers. In response to the serious public health problem in this country, efforts are underway to combat this growing threat. One solution is the advent of Prescription Drug Monitoring Programs (PDMP).

What is a PDMP?

PDMP is a healthcare tool with a variety of applications. The first PDMP appeared in California in 1939, primarily as a benefit for law enforcement tracking illegal drug behaviors. Today’s PDMP has evolved; as an online database of prescribing and dispensing data, PDMP helps identify when a patient obtains multiple prescriptions from different practitioners. Each database is state-run and used to address prescription drug diversion and abuse. PDMPs serve multiple functions. A PDMP is a patient care tool, a drug epidemic early warning system, and a drug diversion and insurance fraud investigation mechanism. The goal of the PDMP is to reduce the impact of prescription drug abuse and diversion.

Areas of Current and Future PDMP Impact

Not all states have PDMP requirements. Those who currently require health care personnel to utilize this system are Arizona, Connecticut, Maine, Minnesota, New York, Virginia, North Carolina, and Rhode Island. These states are seeing drastically reduced incidences of fraudulent patient behavior.

This is especially true in highly populated states such as New York, where improved visibility into prescribing patterns and potential drug-seeking behaviors has been critical to combating the practice of “doctor shopping,” as described above, in which drug addicts and system abusers go from clinic to clinic amassing a pile of prescriptions for the desired controlled substances. Looking toward the future, 12 states have requirements pending, and the hope is that the 29 states plus DC and Guam who currently have no requirement will decide to follow suit soon.

New York’s successful program has expanded to include access to other state databases and information, and this transparency and interoperability might be a prediction of the future of PDMP.

Overall Benefits

Data regarding PDMP use by state clearly shows positive benefits in the states that use these tools. While research into PDMP effectiveness is ongoing, a 2012 study looked at rates of painkiller abuse and misuse in PDMP vs. non-PDMP states from 2003 to 2009 and discovered that in non-PDMP states, rates of abuse and misuse increased more rapidly than in states with such programs.

But PDMPs are not just concerned with legality. Hand-in-hand with reduced fraudulent and abusive behavior is the improvement of identification of and treatment options for those spiraling in the tornado of the addiction epidemic, perhaps the real crowning achievement of these programs. A hallmark of addiction is a lack of self-awareness and honesty regarding one’s own harmful behaviors, and the PDMP becomes a life-saving tool in which doctors and patients can have the transparent conversations needed to kick-start recovery.

DrFirst and ChartLogic

DrFirst has been at the forefront of electronic prescribing of controlled substances (EPCS) since it sent the nation’s first electronic prescription of a controlled substance. In our partnership with DrFirst, ChartLogic is poised to make a huge impact on this current health crisis as part of a joint effort. The marriage of our software with DrFirst’s program makes sense given the proven success of our ambulatory EHR suite that includes Electronic Medical Records, Practice Management, and Billing Services. And we are proud to be part of a solution that is not only changing lives, but also saving them

Read more at chartlogic.com

Sources:

http://www.chartlogic.com/blog/the-power-of-prescription-drug-monitoring-programs/#_ednref1

https://www.ncjrs.gov/pdffiles1/ondcp/pdmp.pdf

https://searchandrescueusa.org/monitoryourpatients/?utm_source=google&utm_medium=ppc&utm_campaign=2018_PFDK_Nonbrand_PDMP&utm_term=pdmp

https://healthitanalytics.com/news/ny-expands-prescription-drug-monitoring-program-to-25-states

https://www.drugrehab.org/the-benefits-of-prescription-drug-monitoring-programs-pdmp/

https://www.drfirst.com/resources/e-prescribing-mandate-map/

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Digital health mergers and acquisitions (M&A) along with venture capital (VC) activities are rapidly increasing. Tempus AI's $1.7 billion acquisition of Personalis is part of a larger trend that is influencing health system operators’ selection of vendors. With $7.4 billion in funding during the first half of 2026, the health-tech industry is undergoing significant transformation.

  • 01Tempus AI acquired Personalis for $1.7 billion.
  • 02Health-tech received $7.4 billion in funding in the first half of 2026.
  • 03M&A activities are influencing vendor choices for health system operators.

Jul 30, 2026

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

In the first half of 2026, digital health AI investments reached $7.4 billion as organizations like CMS, hospitals, and startups increased their adoption of AI. Significant moves include the establishment of a new CMS technology office and a $1.7 billion acquisition in cancer technology. These developments mark an enterprise-level commitment to advancing AI in healthcare.

  • 01Digital health AI investments reached $7.4 billion in H1 2026.
  • 02The CMS established a new technology office to advance healthcare AI.
  • 03A major acquisition in cancer technology totaled $1.7 billion.

Jul 30, 2026

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

The global structural health monitoring (SHM) market is projected to surpass $8.6 billion by 2035. This growth is fueled by the integration of AI analytics, wireless sensor technologies, and the necessity to address aging infrastructure. The expansion reflects a widespread adoption of these technologies in various sectors.

  • 01The SHM market is expected to exceed $8.6 billion by 2035.
  • 02Advancements in AI-powered analytics and wireless sensors are key drivers of market growth.
  • 03Aging infrastructure is creating a demand for enhanced structural health monitoring solutions.

Jul 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512